azathioprine has been researched along with Purine Pyrimidine Metabolism, Inborn Errors in 19 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
"A sex-linked familial neurological disease consisting of cerebral palsy, mental retardation, choreoathetosis, and compulsive aggressive behavior is associated with a loss of an enzyme that participates in purine metabolism, namely, hypoxanthine-guanine phosphoribosyltransferase." | 3.64 | Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. ( Kelley, WN; Rosenbloom, FM; Seegmiller, JE, 1967) |
"Our aim was to assess the cost-effectiveness of phenotyping-based dosing of TPMT activity, genotyping-based screening and no screening (reference) for patients treated with azathioprine." | 1.51 | Modeling the Outcome of Systematic TPMT Genotyping or Phenotyping Before Azathioprine Prescription: A Cost-Effectiveness Analysis. ( Chatellier, G; Durand-Zaleski, I; Loriot, MA; Pallet, N; Zarca, K, 2019) |
" This study aims to detect TPMT polymorphisms and TPMT enzyme activity in Chinese SLE patients and to describe the association between TPMT genotypes and adverse effects of AZA." | 1.40 | Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus. ( Chen, D; Lian, F; Liang, L; Qiu, Q; Wang, Y; Xu, H; Yang, X; Ye, Y; Yuan, S; Zhan, Z, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.79) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 14 (73.68) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Marinaki, AM | 1 |
Arenas-Hernandez, M | 1 |
Tanev, D | 1 |
Peteva, P | 1 |
Fairbanks, L | 1 |
Marinaki, A | 2 |
Ivanova, M | 1 |
Alaikov, T | 1 |
Shivarov, V | 1 |
Jensen, CH | 1 |
Fanciullo, J | 1 |
Zarca, K | 1 |
Durand-Zaleski, I | 1 |
Loriot, MA | 1 |
Chatellier, G | 1 |
Pallet, N | 1 |
Lennard, L | 1 |
Chen, D | 1 |
Lian, F | 1 |
Yuan, S | 1 |
Wang, Y | 1 |
Zhan, Z | 1 |
Ye, Y | 1 |
Qiu, Q | 1 |
Xu, H | 1 |
Liang, L | 1 |
Yang, X | 1 |
Kessler, C | 1 |
Tschumi, S | 1 |
Simonetti, GD | 1 |
Bianchetti, MG | 1 |
Kim, HY | 1 |
Kim, JW | 1 |
Kim, MJ | 1 |
Lee, YM | 1 |
Kang, B | 1 |
Choe, YH | 1 |
Lee, SY | 1 |
Roberts, RL | 2 |
Barclay, ML | 2 |
van Moorsel, SA | 1 |
Bevers, N | 1 |
Meurs, M | 1 |
van Rossum, LK | 1 |
Hooymans, PM | 1 |
Wong, DR | 1 |
Landy, J | 1 |
Bhuva, N | 1 |
Mawdsley, J | 1 |
Mayo, MJ | 1 |
Dewit, O | 1 |
Moreels, T | 1 |
Baert, F | 1 |
Peeters, H | 1 |
Reenaers, C | 1 |
de Vos, M | 1 |
Van Hootegem, P | 1 |
Muls, V | 1 |
Veereman, G | 1 |
Mana, F | 1 |
Van Outryve, M | 1 |
Holvoet, J | 1 |
Naegels, S | 1 |
Piessevaux, H | 1 |
Horsmans, Y | 1 |
Gala, JL | 1 |
Seegmiller, JE | 1 |
Rosenbloom, FM | 1 |
Kelley, WN | 1 |
Westberg, NG | 1 |
Rosén, E | 1 |
Waldenström, J | 1 |
Mizuno, T | 1 |
Segawa, M | 1 |
Kurumada, T | 1 |
Maruyama, H | 1 |
Onisawa, J | 1 |
Asadov, C | 1 |
Aliyeva, G | 1 |
Mustafayeva, K | 1 |
Stiburkova, B | 1 |
Pavelcova, K | 1 |
Petru, L | 1 |
Krijt, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pharmacogenomic Analysis of 6-mercaptopurine in Pediatric Acute Lymphoblastic Leukemia[NCT04770922] | 80 participants (Actual) | Observational | 2021-02-23 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for azathioprine and Purine Pyrimidine Metabolism, Inborn Errors
Article | Year |
---|---|
Reducing risk in thiopurine therapy.
Topics: Azathioprine; Drug Hypersensitivity; Erythrocytes; Female; Genotype; Humans; Male; Mercaptopurine; M | 2020 |
Update on thiopurine pharmacogenetics in inflammatory bowel disease.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Hypersensitivity; Drug-Related Side Effects a | 2015 |
Management of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Drug Hypersensitivity; Hepatitis, Autoimmune; Humans; Immunosuppressive Ag | 2011 |
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
Topics: Antibodies, Monoclonal; Azathioprine; Biotransformation; Crohn Disease; Drug Hypersensitivity; Drug | 2012 |
Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
Topics: Animals; Drug Hypersensitivity; Gene Frequency; Genotyping Techniques; Humans; Mercaptopurine; Methy | 2017 |
14 other studies available for azathioprine and Purine Pyrimidine Metabolism, Inborn Errors
Article | Year |
---|---|
Beware of the Uric Acid: Severe Azathioprine Myelosuppression in a Patient With Juvenile Idiopathic Arthritis and Hereditary Xanthinuria.
Topics: Aldehyde Oxidase; Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Bone Marrow Failure Disor | 2020 |
Point-Counterpoint: TPMT Genotyping for Azathioprine in Adult Medicine.
Topics: Azathioprine; Drug Hypersensitivity; Genotype; Humans; Immunosuppressive Agents; Methyltransferases; | 2017 |
Modeling the Outcome of Systematic TPMT Genotyping or Phenotyping Before Azathioprine Prescription: A Cost-Effectiveness Analysis.
Topics: Antimetabolites; Azathioprine; Cost-Benefit Analysis; Drug Hypersensitivity; Genetic Testing; Geneti | 2019 |
Implementation of TPMT testing.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Cost-Benefit Analysis; Drug Hypersensitivity; Drug La | 2014 |
Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
Topics: Adult; Alleles; Alopecia; Asian People; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort | 2014 |
New-onset bone marrow aplasia in a 15-year-old adolescent with pauci-immune crescentic glomerulonephritis: Questions.
Topics: Adolescent; Azathioprine; Bone Marrow; Drug Hypersensitivity; Glomerulonephritis; Humans; Immunosupp | 2015 |
Safe azathioprine treatment in a pediatric ulcerative colitis patient with TPMT*16 by thiopurine metabolite monitoring.
Topics: Adolescent; Azathioprine; Colitis, Ulcerative; Drug Hypersensitivity; Humans; Male; Methyltransferas | 2014 |
Azathioprine Therapy in a Pediatric TPMT-Deficient Patient-Still an Option.
Topics: Adolescent; Azathioprine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Monitoring; | 2017 |
Novel thiopurine methyltransferase variant TPMT*28 results in a misdiagnosis of TPMT deficiency.
Topics: Amino Acid Substitution; Azathioprine; Colitis, Ulcerative; Diagnostic Errors; Drug Hypersensitivity | 2011 |
Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients.
Topics: Adolescent; Adult; Aged; Azathioprine; DNA Mutational Analysis; Drug Hypersensitivity; Female; Genot | 2011 |
Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.
Topics: Adenine; Adenine Nucleotides; Adolescent; Adult; Aggression; Athetosis; Azathioprine; Cerebral Palsy | 1967 |
Recessive X-linked hyperuricemia with gout and renal damage, normal activity of hypoxanthine phosphoribosyltransferase and resistance to azaguanine.
Topics: Adenine Phosphoribosyltransferase; Adolescent; Adult; Azaguanine; Azathioprine; Erythrocytes; Female | 1979 |
Clinical and therapeutic aspects of the Lesch-Nyhan syndrome in Japanese children.
Topics: Allopurinol; Athetosis; Azathioprine; Benzofurans; Child; Child, Preschool; Guanine; Humans; Hypoxan | 1970 |
Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II).
Topics: Adult; Aldehyde Oxidase; Female; Humans; Mercaptopurine; Methyltransferases; Polymorphism, Genetic; | 2018 |